共 50 条
- [1] Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation [J]. DIABETES CARE, 2010, 33 (06) : 1395 - 1402
- [2] Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (25) : 2878 - 2886
- [3] Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation (vol 33, pg 1395, 2010) [J]. DIABETES CARE, 2010, 33 (09) : 2129 - 2131
- [4] Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation (vol 33, pg 1395, 2010) [J]. DIABETES CARE, 2011, 34 (01) : 247 - 248
- [5] Review of an Article: Aspirin for primary prevention of cardiovascular events in people with diabetes. (2010). A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association (AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33: 6; June 2010; 1395-1402. [J]. JOURNAL OF VASCULAR NURSING, 2010, 28 (04) : 154 - 155
- [6] Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association [J]. CIRCULATION, 2009, 119 (02) : 351 - 357
- [7] Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association [J]. DIABETES CARE, 2009, 32 (01) : 187 - 192
- [8] Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (03) : 298 - 304